Quadrant Capital Group’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Buy
7,511
+3,131
+71% +$84K 0.01% 1132
2026
Q1
$90.9K Sell
4,380
-11,831
-73% -$279K ﹤0.01% 1504
2025
Q4
$526K Buy
16,211
+13,134
+427% +$563K 0.02% 890
2025
Q3
$175K Sell
3,077
-10,611
-78% -$544K 0.01% 1308
2025
Q2
$682K Sell
13,688
-4,606
-25% -$208K 0.02% 683
2025
Q1
$541K Buy
18,294
+16,113
+739% +$599K 0.02% 695
2024
Q4
$52.7K Buy
+2,181
New +$54K ﹤0.01% 1383
2024
Q3
Sell
-69
Closed -$1.39K 2766
2024
Q2
$1.39K Buy
69
+44
+176% +$732 ﹤0.01% 2525
2024
Q1
$387 Buy
+25
New +$282 ﹤0.01% 2660
2023
Q4
Sell
-332
Closed -$2.09K 2730
2023
Q3
$2.09K Buy
+332
New +$2.47K ﹤0.01% 2379

Other funds holding HIMS

Quadrant Capital Group's HIMS Position: Q2 2026 in Review

Quadrant Capital Group increased its Hims & Hers Health (HIMS) stake by 71% in Q2 2026, buying an estimated $84K and bringing the position to 7,511 shares worth $260K. The position accounts for 0.01% of the portfolio, ranked #1132.

Quadrant Capital Group first reported a position in HIMS in Q3 2023 and has held it in 10 quarters since. The position peaked at $682K in Q2 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Quadrant Capital Group held 7,511 shares of Hims & Hers Health worth $260K as of Q2 2026.
  • Quadrant Capital Group bought 3,131 Hims & Hers Health shares in Q2 2026, an estimated $84K.
  • Hims & Hers Health made up 0.01% of Quadrant Capital Group's portfolio in Q2 2026, its #1132 holding.
  • Quadrant Capital Group first reported a position in Hims & Hers Health in Q3 2023 and has held it in 10 quarters since.
  • Quadrant Capital Group's Hims & Hers Health position peaked at $682K in Q2 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.